|
Andrich J, Saft C, Gerlach M, Schneider B, Arz A, Kuhn W, Muller T. Coenzyme Q10
serum levels in Huntington's disease. J Neural Transm Suppl. 2004;(68):111-6.
Baggio E, Gandini R, Plancher AC, et al. Italian multi-center study on the
safety and efficacy of Coenzyme Q10 as adjunctive therapy in heart failure.
Co Q10 Drug Surveillance Investigators. Molecular Aspects in Medicine 1994;15(Suppl.):S287-94.
Beal MF, Shults CW. Effects of Coenzyme Q10 in Huntington's disease and early
Parkinson's disease. Biofactors. 2003;18(1-4):153-61.
Beal MF. Coenzyme Q10 administration and its potential for treatment of neurodegenerative
diseases. Biofactors. 1999;9(2-4):261-6.
Beal MF. Coenzyme Q10 as a possible treatment for neurodegenerative diseases.
Free Radic Res. 2002 Apr;36(4):455-60.
Chen YF, Lin YS, and Wu SC. Effectiveness of conenzyme Q10 on myocardial preservation
during hypothermic cardioplegic arrest. Journal of Thoracic and Cardiovascular
Surgery 1994;107:242-47.
Craft, N.E., Tucker, R.T., Chitchumroonchokchai, C., Failla, M.L., Bhagavan,
H.N. Assessment of Coenzyme Q10 Bioavailability Using a Coupled in vitro Digestion/Caco-2
Human Intestinal Cell Model. FASEB Journal. 2005; 19(4): A449.
Digiesi V, Cantini F, Bisi G, et al. Mechanisms of action of Coenzyme Q10 in
essential hypertension. Current Therapeutic Research 1992;51:668-72.
Grant WB. Year 2000 prevalence of Alzheimer disease in the United States. Arch
Neurol. 2004 May;61(5):802-3; author reply 803.
Hebert LE, Bienias JL, Bennett DA, Evans DA, and Scherr PA. Year 2000 Prevalence
of Alzheimer Disease in the United States—Reply. Arch Neurol. 2004;61:803.
Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF. Energy metabolism defects in Huntington's
disease and effects of coenzyme Q10. Ann Neurol. 1997 Feb;41(2):160-5.
Muller T, Buttner T, Gholipour AF, Kuhn W. Coenzyme Q10 supplementation provides
mild symptomatic benefit in patients with Parkinson's disease. Neurosci Lett.
2003 May 8;341(3):201-4.
Poggesi L, Galanti G, Comeglio M, et al. Effect of Coenzyme Q10 on left ventricular
function in patients with dilative cardiomyopathy: a medium-term randomized
double-blind study versus placebo. Current Therapeutic Research 1991;49:878-86.
Rim EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk
of coronary heart disease in men. New England Journal of Medicine 1993;328(20):1450-56.
Shults CW, Flint Beal M, Song D, Fontaine D. Pilot trial of high dosages of
coenzyme Q10 in patients with Parkinson's disease. Exp Neurol. 2004 Aug;188(2):491-4.
Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J,
Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL,
Kurlan R, Molho E, Harrison M, Lew M; Parkinson Study Group. Effects of coenzyme
Q10 in early Parkinson disease: evidence of slowing of the functional decline.
Arch Neurol. 2002 Oct;59(10):1541-50.
Shults CW. Coenzyme Q10 in neurodegenerative diseases. Curr Med Chem. 2003
Oct;10(19):1917-21.
|
